REMEDY FOR DISEASE ASSOCIATED WITH BONE MASS LOSS CONTAINING EP4 AGONIST AS ACTIVE INGREDIENT

REMEDY FOR DISEASE ASSOCIATED WITH BONE MASS LOSS CONTAINING EP4 AGONIST AS ACTIVE INGREDIENT

PROBLEM TO BE SOLVED: To provide a topically administering agent for preventing and/or treating diseases associated with bone mass loss. SOLUTION: A compound having a prostaglandin skeleton selected from compounds expressed by general formula (I-2) and general formula (I-3) as an active ingredient,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANBE TORU, YOSHIDA HIDEYUKI, NISHIURA AKIO, ABE NOBUTAKA, MARUYAMA TORU, KOBAYASHI KAORU, MARUYAMA TAKAYUKI
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a topically administering agent for preventing and/or treating diseases associated with bone mass loss. SOLUTION: A compound having a prostaglandin skeleton selected from compounds expressed by general formula (I-2) and general formula (I-3) as an active ingredient, its nontoxic salt or its cyclodextrin inclusion complex is used. COPYRIGHT: (C)2009,JPO&INPIT